BMO Capital Markets Issues Pessimistic Forecast for Phreesia (NYSE:PHR) Stock Price

Phreesia (NYSE:PHR) had its price objective dropped by investment analysts at BMO Capital Markets from $32.00 to $14.00 in a report issued on Tuesday,Benzinga reports. The firm currently has an “outperform” rating on the stock. BMO Capital Markets’ price target would suggest a potential upside of 22.44% from the company’s current price.

Several other equities research analysts have also issued reports on PHR. DA Davidson lowered their target price on shares of Phreesia from $35.00 to $30.00 and set a “buy” rating on the stock in a research note on Friday, January 23rd. Mizuho reduced their price target on Phreesia from $22.00 to $19.00 and set an “outperform” rating for the company in a report on Tuesday, March 24th. Canaccord Genuity Group lowered their price target on Phreesia from $33.00 to $22.00 and set a “buy” rating on the stock in a research report on Tuesday. Robert W. Baird reissued a “neutral” rating and issued a $10.00 price objective (down from $25.00) on shares of Phreesia in a report on Tuesday. Finally, JPMorgan Chase & Co. restated a “neutral” rating and issued a $16.00 price objective on shares of Phreesia in a research report on Tuesday. Thirteen investment analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $22.71.

Phreesia Stock Performance

PHR opened at $11.43 on Tuesday. The firm has a fifty day moving average price of $12.51 and a 200 day moving average price of $17.68. Phreesia has a 1 year low of $10.75 and a 1 year high of $32.76. The stock has a market cap of $689.36 million, a P/E ratio of -114.33 and a beta of 0.67. The company has a debt-to-equity ratio of 0.01, a current ratio of 2.44 and a quick ratio of 2.44.

Phreesia (NYSE:PHR) last released its quarterly earnings results on Monday, March 30th. The company reported $0.02 EPS for the quarter, missing the consensus estimate of $0.07 by ($0.05). Phreesia had a negative net margin of 1.16% and a negative return on equity of 1.31%. The firm had revenue of $127.07 million for the quarter, compared to analyst estimates of $126.75 million. During the same quarter in the prior year, the business posted ($0.11) EPS. The firm’s quarterly revenue was up 15.9% compared to the same quarter last year. Equities research analysts anticipate that Phreesia will post -1.1 earnings per share for the current year.

Insider Activity at Phreesia

In other Phreesia news, insider David Linetsky sold 6,106 shares of the stock in a transaction that occurred on Thursday, January 8th. The stock was sold at an average price of $17.01, for a total transaction of $103,863.06. Following the completion of the transaction, the insider owned 231,723 shares of the company’s stock, valued at $3,941,608.23. This represents a 2.57% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Balaji Gandhi sold 8,009 shares of the firm’s stock in a transaction that occurred on Thursday, January 8th. The shares were sold at an average price of $17.01, for a total value of $136,233.09. Following the completion of the transaction, the chief financial officer owned 156,231 shares in the company, valued at approximately $2,657,489.31. This trade represents a 4.88% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders sold 70,358 shares of company stock valued at $1,123,569. 5.50% of the stock is owned by corporate insiders.

Institutional Trading of Phreesia

Large investors have recently made changes to their positions in the company. Granahan Investment Management LLC raised its stake in Phreesia by 73.8% in the 4th quarter. Granahan Investment Management LLC now owns 2,399,613 shares of the company’s stock valued at $40,601,000 after purchasing an additional 1,018,987 shares during the last quarter. Prosight Management LP acquired a new stake in Phreesia during the 4th quarter worth $16,533,000. Millennium Management LLC grew its holdings in shares of Phreesia by 730.7% during the third quarter. Millennium Management LLC now owns 1,064,132 shares of the company’s stock worth $25,028,000 after buying an additional 936,033 shares in the last quarter. Jacobs Levy Equity Management Inc. acquired a new stake in shares of Phreesia in the fourth quarter valued at about $15,213,000. Finally, Greenhouse Funds LLLP raised its position in shares of Phreesia by 16.8% in the third quarter. Greenhouse Funds LLLP now owns 3,882,527 shares of the company’s stock valued at $91,317,000 after buying an additional 557,265 shares during the last quarter. 92.10% of the stock is currently owned by hedge funds and other institutional investors.

Key Phreesia News

Here are the key news stories impacting Phreesia this week:

• Positive Sentiment: Company reported positive GAAP net income and strong free cash flow for the fiscal year — exceeded internal targets including crossing $100M of Adjusted EBITDA and roughly $50M+ of free cash flow, a proof point for profitability and capital-generation that can support valuation. Phreesia Announces Fourth Quarter Fiscal 2026 Results
• Positive Sentiment: Management highlighted record revenue growth and strategic initiatives on the Q4 call, indicating underlying demand and execution on product/partnership priorities that investors view as longer-term upside. Phreesia Inc (PHR) Q4 2026 Earnings Call Highlights: Record Revenue Growth and Strategic …
• Neutral Sentiment: Full earnings-call transcript is available for detail seekers — useful for investors who want management’s color on drivers, margin improvement, and the AccessOne integration timeline. Phreesia, Inc. (PHR) Q4 2026 Earnings Call Transcript
• Neutral Sentiment: Several analysts revised expectations heading into the print, lowering EPS/forecast assumptions — shows sentiment was already shifting and likely amplified intraday moves. Top Wall Street Forecasters Revamp Phreesia Expectations Ahead Of Q4 Earnings
• Negative Sentiment: Management cut near-term outlook: FY2027 revenue was guided to $510M–$520M and executives warned of headwinds from the network solutions business and integration-related pressure from AccessOne — a driver of the recent sell-off. Phreesia outlines $510M–$520M revenue target for 2027 amid network solutions headwinds and AccessOne integration
• Negative Sentiment: Market reaction: shares plunged after the EPS miss and guidance cut (reports of a ~22% drop and all-time lows in some sessions) — short-term momentum and sentiment risk remain. Phreesia shares tumble 22% on earnings miss, slashed guidance

Phreesia Company Profile

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.